A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors

Clinical trial NCT07253116 · RECRUITING

Trial details

NCT number: NCT07253116
Sponsor: Nanjing Jingao biomidical technology Co. Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-11-20
Primary completion: 2028-11-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.